SenesTech Yönetim

Yönetim kriter kontrolleri 3/4

We currently do not have sufficient information about the CEO.

Anahtar bilgiler

Joel Fruendt

İcra Kurulu Başkanı

US$343.0k

Toplam tazminat

CEO maaş yüzdesi	99.1%
CEO görev süresi	2yrs
CEO sahipliği	0.01%
Yönetim ortalama görev süresi	Veri yok
Yönetim Kurulu ortalama görev süresi	4yrs

Son yönetim güncellemeleri

Recent updates

We Think SenesTech (NASDAQ:SNES) Needs To Drive Business Growth Carefully

Aug 24

SenesTech EPS of -$0.56

Nov 11

CEO Tazminat Analizi

Joel Fruendt'un ücretlendirmesi SenesTech'un kazancına kıyasla nasıl değişti?
Tarih	Toplam Tazminat	Maaş	Şirket Kazançları
Jun 30 2024	n/a	n/a	-US$7m
Mar 31 2024	n/a	n/a	-US$8m
Dec 31 2023	US$343k	US$340k	-US$8m
Sep 30 2023	n/a	n/a	-US$8m
Jun 30 2023	n/a	n/a	-US$9m
Mar 31 2023	n/a	n/a	-US$9m
Dec 31 2022	US$458k	US$44k	-US$10m

Tazminat ve Piyasa: Joel's total compensation ($USD343.04K) is below average for companies of similar size in the US market ($USD655.65K).

Tazminat ve Kazançlar: Joel's compensation has been consistent with company performance over the past year.

CEO

Joel Fruendt (63 yo)

2yrs

Görev süresi

US$343,044

Tazminat

Mr. Joel L. Fruendt serves as Chief Executive Officer and Director of SenesTech, Inc. since November 15, 2022. He serves as President at SenesTech, Inc. since December 2022. Most recently he served as Pres...

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Joel Fruendt	CEO, President & Director	2yrs	US$343.04k	0.011% $ 285.0
Anders Field	Advisor	no data	Veri yok	Veri yok
Matthew Szot	Independent Vice-Chairman of the Board	8.9yrs	US$103.50k	0.00020% $ 5.3
Jacob Leach	Independent Director	4yrs	US$51.00k	0.0061% $ 160.5
Julia Williams	Director Emeritus	4yrs	US$49.63k	Veri yok
Bill Calloway	Advisor	no data	Veri yok	Veri yok
Jamie Bechtel	Independent Chairman of the Board & Lead Independent Director	6.8yrs	US$118.70k	0.00010% $ 2.6
Phil Grandinetti	Independent Director	4yrs	US$60.00k	0% $ 0

4.0yrs

Ortalama Görev Süresi

52yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: SNES's board of directors are considered experienced (4 years average tenure).

SenesTech Yönetim

Yönetim kriter kontrolleri 3/4

Anahtar bilgiler

Son yönetim güncellemeleri

SenesTech, Inc., Annual General Meeting, Jul 11, 2024

Senestech Names Nicole Williams as Chief Revenue Officer

SenesTech, Inc. Announces Executive Changes

SenesTech Announces Resignation of K.C. Kavanagh as Member of Board of Directors

SenesTech, Inc., Annual General Meeting, Jun 23, 2022

High number of new directors

Recent updates

SenesTech, Inc.'s Evolve™ Registers in Hong Kong; Offering a Revolutionary Non-Lethal Rodent Control Solution

Second quarter 2024 earnings: EPS exceeds analyst expectations while revenues lag behind

SenesTech Receives Notification from Nasdaq Due to Non-Compliance with Nasdaq’s Audit Committee Requirements as Set Forth in Nasdaq Listing Rule 5605

SenesTech, Inc. to Report Q2, 2024 Results on Aug 08, 2024

New major risk - Share price stability

SenesTech, Inc. has filed a Follow-on Equity Offering in the amount of $1.575944 million.

SenesTech, Inc., Annual General Meeting, Jul 11, 2024

Consensus EPS estimates fall by 67%

First quarter 2024 earnings: EPS and revenues miss analyst expectations

SenesTech, Inc. to Report Q1, 2024 Results on May 09, 2024

Nasdaq Determines SenesTech Eligible for an Additional 180 Calendar Day Period, or Until August 19, 2024, to Regain Compliance with the Minimum Bid Price Requirement

Consensus EPS estimates upgraded to US$0.66 loss

New major risk - Financial position

SenesTech, Inc. to Report Q4, 2023 Results on Feb 21, 2024

SenesTech Partners with Global Leader in Irrigation Solutions to Expand Evolve Soft Bait to Open Field Agriculture Applications

SenesTech's ContraPest Registered for Use in Puerto Rico to Combat Rat Infestations

SenesTech, Inc. has completed a Follow-on Equity Offering.

New major risk - Financial position

SenesTech, Inc. has completed a Follow-on Equity Offering in the amount of $5 million.

SenesTech Receives a Letter from the Listing Qualifications Staff of the Nasdaq Stock Market

Third quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

SenesTech, Inc. to Report Q3, 2023 Results on Nov 09, 2023

SenesTech Taking Orders for Evolve™ Soft Bait for Rodent Fertility Control

SenesTech, Inc. Launches Evolve Soft Bait for Rodent Fertility Control

New minor risk - Share price stability

SenesTech Receives Non-Compliance Letter from Nasdaq

Second quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

SenesTech, Inc. to Report Q2, 2023 Results on Aug 10, 2023

SenesTech, Inc. Launches Isolate Bait System for Contrapest

First quarter 2023 earnings: EPS and revenues miss analyst expectations

SenesTech, Inc. to Report Q1, 2023 Results on May 11, 2023

No longer forecast to breakeven

Full year 2022 earnings released: US$0.016 loss per share (vs US$14.78 loss in FY 2021)

Senestech Names Nicole Williams as Chief Revenue Officer

Price target decreased to US$4.00

SenesTech, Inc. Announces Executive Changes

SenesTech, Inc. to Report Q3, 2022 Results on Nov 14, 2022

SenesTech Announces Resignation of K.C. Kavanagh as Member of Board of Directors

Second quarter 2022 earnings: EPS and revenues miss analyst expectations

SenesTech, Inc. to Report Q2, 2022 Results on Aug 11, 2022

SenesTech, Inc. Announces its New Elevate Bait System with ContraPest Now Available in California

SenesTech, Inc. Announces its New Elevate Bait System with ContraPest Available for Sale

First quarter 2022 earnings: EPS and revenues exceed analyst expectations

SenesTech, Inc. to Report Q1, 2022 Results on May 12, 2022

SenesTech, Inc., Annual General Meeting, Jun 23, 2022

Price target decreased to US$4.00

Consensus forecasts updated

Full year 2021 earnings: EPS exceeds analyst expectations while revenues lag behind

High number of new directors

Third quarter 2021 earnings released: US$0.18 loss per share (vs US$0.56 loss in 3Q 2020)

We Think SenesTech (NASDAQ:SNES) Needs To Drive Business Growth Carefully

Consensus forecasts updated

Independent Director recently bought US$229k worth of stock

Second quarter 2021 earnings released: US$0.14 loss per share (vs US$0.59 loss in 2Q 2020)

First quarter 2021 earnings released: US$0.22 loss per share (vs US$1.70 loss in 1Q 2020)

Forecast to breakeven in 2025

Full year 2020 earnings released: US$2.64 loss per share (vs US$7.69 loss in FY 2019)

SenesTech, Inc. to Report Q4, 2020 Results on Mar 25, 2021

New 90-day high: US$2.28

SenesTech, Inc. announced that it has received $10.000004 million in funding

SenesTech, Inc. announced that it expects to receive $10.000004 million in funding

New 90-day high: US$1.90

Revenue beats expectations, earnings disappoint

Third quarter 2020 earnings released: US$0.56 loss per share

SenesTech, Inc. Restructures Board for Commercial Growth

SenesTech EPS of -$0.56

SenesTech, Inc. to Report Q3, 2020 Results on Nov 11, 2020

New 90-day low: US$1.36

Contrapest® Added to San Francisco Reduced Risk Pesticide List